
Pituitary Tumor: Types, Symptoms, Diagnosis and Treatment (2026 Guide)
Filters & Insights
Medically reviewed content · Published 2026 · Last reviewed August 2026
A pituitary tumor is an abnormal growth arising in or around the pituitary gland, a small gland at the base of the brain that regulates growth, thyroid function, adrenal function, reproductive hormones, lactation, and water balance. The most common pituitary tumors are pituitary adenomas — increasingly called pituitary neuroendocrine tumors (PitNETs) in current classification — which may produce excess hormones, cause hormone deficiency, or press on nearby structures like the optic nerves. Most pituitary tumors are not cancer: true pituitary carcinoma, defined by spread outside the central nervous system, is exceptionally rare. But “not cancer” doesn’t mean harmless — pituitary tumors can cause real, sometimes serious problems through hormone excess, hormone deficiency, or local pressure, and require proper evaluation and, often, active treatment.
This guide explains the main types of pituitary tumor, how they’re diagnosed, and current treatment options including medication, transsphenoidal surgery, radiation, and hormone replacement along with what treatment for a pituitary tumor and its cost look like for international patients considering care in India. This is general medical education, not a diagnosis or an individual treatment recommendation.
Is a Pituitary Tumor Cancer?
Most pituitary tumors are not cancerous. Pituitary carcinoma is extremely rare and is defined by spread to distant sites, rather than simply growing aggressively. However, even non-cancerous tumors can cause serious problems through hormone production, vision changes, or pressure on nearby structures.
Pituitary Adenoma vs. PitNET
Many tumors traditionally called pituitary adenomas are now termed pituitary neuroendocrine tumors (PitNETs). Both terms are still used, and neither means the tumor is cancerous. The newer terminology reflects a more detailed understanding of their biological characteristics.
Pituitary Gland Anatomy
The pituitary gland is a small endocrine gland located at the base of the brain within the sella turcica. It lies close to the optic chiasm, where the optic nerves cross, so larger tumors can cause visual problems.
The gland connects to the hypothalamus through the pituitary stalk and helps regulate several major hormone systems, including growth, thyroid function, reproduction, and stress responses. Although closely connected to the brain, the pituitary is technically an endocrine gland rather than brain tissue itself.
Types of Pituitary Tumors
Pituitary tumors are classified by hormone production, cell lineage, size, and clinical behavior. At a basic level, they’re divided into functioning tumors (which produce excess biologically active hormone causing a recognizable syndrome) and nonfunctioning tumors (which don’t cause a clinically significant hormone-excess syndrome — though “nonfunctioning” doesn’t mean biologically inactive or harmless). Some tumors produce more than one hormone, though this is less common than single-hormone secretion.
| Feature | Functioning Tumor | Nonfunctioning Tumor |
|---|---|---|
| Hormone Effect | Produces excess hormone causing a recognizable clinical syndrome | Doesn’t cause a clinically significant hormone-excess syndrome |
| How It’s Typically Found | Often via hormone-related symptoms, sometimes while still small | Often incidentally, or once large enough to cause pressure-related symptoms |
| Named Types | Prolactinoma, GH-secreting (acromegaly), ACTH-secreting (Cushing disease), TSH-secreting, gonadotroph | No specific hormone-driven subtype; classified by size and growth pattern |
Prolactinoma
Prolactinoma is a prolactin-secreting pituitary tumor and one of the most common functioning pituitary tumors. Symptoms may include:
- Irregular or absent periods and infertility in women
- Reduced libido and erectile dysfunction in men
- Unexpected breast milk production (galactorrhea)
- Headaches or vision problems with larger tumors
An elevated prolactin level does not always mean prolactinoma. Pregnancy, breastfeeding, certain medications, hypothyroidism, stress, kidney disease, and other conditions can increase prolactin. Doctors consider the full clinical picture and may also test for macroprolactin, a less active form that can cause elevated results.
Treatment: Medication is usually the first-line treatment rather than surgery. Cabergoline or bromocriptine (dopamine agonists) can reduce prolactin levels and often shrink the tumor. Surgery is generally considered when medication is ineffective, poorly tolerated, or unsuitable.
| Feature | Cabergoline | Bromocriptine |
|---|---|---|
| Dosing Frequency | Typically once or twice weekly | Typically daily |
| General Tolerability | Often better tolerated by more patients | More established long-term safety data, including in pregnancy |
| Common Use Case | Often preferred as first-line for many patients given dosing convenience | Sometimes preferred when pregnancy is being planned or has occurred, based on individual discussion with the treating endocrinologist |
Growth Hormone-Secreting Tumors
Excess GH raises IGF-1 and causes acromegaly in adults or gigantism in children. Symptoms include enlarged hands and feet, facial changes, sweating, joint pain, headaches, sleep apnea, and diabetes. Diagnosis involves IGF-1 testing, glucose suppression testing, and pituitary MRI.
Treatment: Transsphenoidal surgery is usually first-line. If disease persists, medications such as octreotide, lanreotide, or pegvisomant may be used. Radiation is considered in selected cases.
ACTH-Secreting Tumors (Cushing Disease)
These tumors produce excess ACTH, causing high cortisol. Symptoms may include central weight gain, rounded face, muscle weakness, easy bruising, purple stretch marks, high blood pressure, diabetes, and osteoporosis.
Treatment: Transsphenoidal surgery is generally preferred, with medication or radiation used when disease persists or recurs.
TSH-Secreting Tumors
These rare tumors cause excess thyroid hormone and symptoms such as palpitations, tremor, sweating, heat intolerance, and weight loss. Treatment may include surgery, medication, or radiation.
Gonadotroph and Nonfunctioning Tumors
These tumors usually don’t cause hormone-excess symptoms. They may be discovered because of headaches, vision problems, or hormone deficiencies.
Common Symptoms
Pituitary tumors may cause:
- Headaches
- Peripheral vision loss
- Double vision
- Fatigue or weakness
- Menstrual irregularities
- Reduced libido
- Infertility
- Excessive thirst and urination
Large tumors can compress the optic chiasm, affecting peripheral vision.
Microadenoma vs. Macroadenoma
- Microadenoma: Less than 10 mm
- Macroadenoma: 10 mm or larger
Size alone does not determine treatment. Hormone activity, growth, symptoms, and proximity to the optic chiasm are also important.
Diagnosis
Evaluation may include hormone tests, pituitary MRI, visual-field testing, and assessment of pituitary function. Pathology after surgery can further identify tumor type and characteristics.
Treatment
Treatment options include observation, medication, transsphenoidal surgery, radiation therapy, and hormone replacement. The appropriate approach depends on the tumor’s type and individual characteristics.
Pituitary apoplexy, causing sudden severe headache with vision changes, vomiting, or altered consciousness, requires emergency medical assessment.
Long-Term Follow-Up
Regular MRI scans, hormone testing, and visual assessments may be needed. Most pituitary tumors can be effectively controlled, but some require long-term or lifelong monitoring.
Pituitary Tumor Treatment Cost in India
| Component | Approx. Cost (USD) | What Drives the Range |
|---|---|---|
| Endocrinology + neurosurgical consultation | $50–$300 | Specialist seniority, number of opinions |
| Hormonal blood panel | $100–$500 | Number and type of tests |
| Pituitary MRI (including dynamic protocol where needed) | $200–$700 | Sequences used, contrast |
| Visual field testing | $50–$150 | Standalone vs. bundled with ophthalmology visit |
| Transsphenoidal endoscopic surgery | $4,000–$10,000 | Complexity, ICU stay, length of hospitalization |
| Craniotomy (for selected complex/large tumors) | $10,000–$20,000 | Rarely needed; more complex and costly than transsphenoidal approach |
| Somatostatin analogue therapy for acromegaly (per month) | $500–$2,500+ | Drug, dose — often an expensive lifelong therapy |
| Dopamine agonist therapy for prolactinoma (per month) | $20–$100 | Far less costly than somatostatin analogues; typically the most affordable ongoing therapy |
| Radiation therapy (course) | $3,000–$8,000 | Technique (radiosurgery vs. fractionated), number of sessions |
| Hormone replacement therapy (ongoing) | $20–$150/month | Number of hormones requiring replacement |
A cost pattern specific to pituitary tumors is worth flagging directly: unlike most of the cancer topics in this series, the single largest long-term cost driver for many pituitary tumor patients isn’t surgery — it’s ongoing medication, particularly somatostatin analogue therapy for acromegaly not fully controlled by surgery, which published international pricing data (from outside India, but informative on the general cost structure of this drug class) shows can run many thousands of dollars per year, potentially for life.
By contrast, prolactinoma medication is comparatively inexpensive. If your specific diagnosis is acromegaly, budgeting for years of ongoing somatostatin analogue therapy not just the surgery itself — is essential to understanding realistic total cost, and this is exactly the kind of figure that needs a direct, written quote from your treating endocrinologist rather than a general estimate, since national and hospital-specific drug pricing varies substantially. As with other topics in this series, request an itemized quote based on your own diagnosis and proposed treatment plan.
Why International Patients Consider India for Pituitary Tumor Care, and How to Choose a Center
India has developed substantial capability in pituitary neurosurgery and neuroendocrinology, including endoscopic endonasal surgery, advanced pituitary MRI, and endocrine testing infrastructure — for international patients, the appeal is typically this combination of capability with costs generally lower than the US, UK, or much of Europe. India isn’t automatically “the best” choice for every patient, however; several countries offer strong pituitary and neuroendocrine programs, and the right choice depends on an individual patient’s specific tumor type, budget, and travel considerations.
When evaluating a center for pituitary tumor care — in India or anywhere — look for:
- A neuroendocrinologist and a pituitary-focused neurosurgeon, not general endocrinology or general neurosurgery coverage alone
- A neuroradiologist experienced in pituitary-protocol MRI
- A neuro-ophthalmologist for visual-field assessment where relevant
- Endoscopic skull-base surgery capability specifically, not just general neurosurgery
- In-house hormonal laboratory testing with reliable turnaround
- Radiation oncology, including stereotactic radiosurgery capability where relevant
- A genuine multidisciplinary pituitary tumor board
- Established international patient services (visa letters, coordination, interpreter support)
Ask directly about the center’s specific pituitary surgery case volume, not just general neurosurgery volume, and verify credentials independently rather than relying on third-party “top hospital” rankings.
The International Patient Treatment Journey
- Share existing MRI and medical reports for review
- Provide hormone test results already obtained
- Confirm tumor type and hormone secretion status
- Review tumor size and location relative to the optic chiasm and cavernous sinus
- Multidisciplinary neuroendocrine/neurosurgical specialist opinion
- Treatment plan developed, with alternatives explained
- Hospital and specialist confirmation
- Written, itemized cost estimate
- Medical visa guidance
- Travel and accommodation arrangements
- Treatment delivery
- Hormone and MRI/visual follow-up planning
- Long-term endocrine care coordination
- Remote follow-up and report-sharing with the home-country physician
No credible provider can guarantee a diagnosis, surgical eligibility, complete tumor removal, hormone normalization, vision recovery, cure, an exact final cost, or visa approval before reviewing a patient’s actual imaging and hormone results be cautious of any provider offering these guarantees upfront.
Questions to Ask Your Pituitary Team
- What type of pituitary tumor do I have — functioning or nonfunctioning, and if functioning, which hormone?
- Is my prolactin elevated because of a tumor, or could another cause explain it?
- What is my tumor’s size — is it a microadenoma or macroadenoma?
- Is the optic chiasm involved? Is the cavernous sinus involved?
- Do I need a visual-field test?
- Do I have any pituitary hormone deficiencies, and would I need hormone replacement?
- Is surgery recommended, or is medication the better first step for my specific tumor type?
- If I have a prolactinoma, has medication genuinely been tried and given a fair chance before considering surgery?
- Would radiation be useful in my situation, now or in the future?
- What are the risks to my normal pituitary function from the proposed treatment?
- What is my risk of recurrence?
- Will I need lifelong hormone monitoring, and what would that involve?
How Shifam Health Helps International Pituitary Tumor Patients
Shifam Health is a medical tourism facilitator, not a hospital, pituitary clinic, neurosurgery center, or endocrinology clinic — we don’t diagnose pituitary tumors or determine treatment plans. What we do is help international patients navigate the practical side of accessing pituitary tumor care in India: coordinating the review of imaging and hormone results by relevant specialists, helping identify hospitals with genuine pituitary neurosurgery and neuroendocrine capability, obtaining written treatment and cost estimates, assisting with medical visa documentation, arranging airport pickup and accommodation, providing interpreter support where needed, and staying in touch for follow-up communication once you return home.
If you or someone you’re caring for has received a pituitary tumor diagnosis, share your available reports with our team on WhatsApp or through a quick inquiry form — there’s no obligation, and we typically respond within 24 hours.
Frequently Asked Questions
Most are not — true pituitary carcinoma, defined by spread beyond the central nervous system, is exceptionally rare. However, even non-cancerous pituitary tumors can cause serious hormonal or visual problems if untreated.
The traditional term for the most common type of pituitary tumor increasingly also called a pituitary neuroendocrine tumor (PitNET) in current classification, without implying malignancy.
Prolactinoma is one cause, but pregnancy, breastfeeding, certain medications, hypothyroidism, stress, and kidney disease can all elevate prolactin — a single elevated result doesn’t confirm prolactinoma.
A condition caused by excess growth hormone, usually from a pituitary tumor, causing gradual enlargement of the hands, feet, and facial features along with other systemic effects in adults.
A specific form of Cushing syndrome caused by a pituitary tumor producing excess ACTH, which drives excess cortisol production not interchangeable with the broader term Cushing syndrome, which includes non-pituitary causes.
A pituitary tumor smaller than 10 mm.
A pituitary tumor 10 mm or larger — size alone doesn’t determine whether treatment is needed.
Yes, larger tumors can compress the optic chiasm, typically causing peripheral vision loss, which can develop gradually and go unnoticed without formal testing.
It can, but headache is nonspecific and has many other, more common causes — headache alone doesn’t suggest a pituitary tumor.
Through hormonal blood testing, pituitary MRI, and, when vision may be affected, formal visual-field testing — the specific tests used depend on the suspected tumor type.
People Ask Further Questions
Usually not before treatment — MRI and hormone testing are generally sufficient for diagnosis and planning; pathology from tissue obtained during surgery, when performed, provides further detail afterward.
The standard surgical approach for pituitary tumors, accessing the gland through the nose and sphenoid sinus rather than through an open skull incision.
Yes — medication (dopamine agonists like cabergoline or bromocriptine) is generally the main first-line treatment and is effective for most patients.
Dopamine agonist medications used to treat prolactinoma by lowering prolactin and shrinking the tumor; they differ mainly in dosing frequency and specific clinical considerations.
Yes, generally for residual or recurrent tumor not adequately controlled by surgery or medication, using either stereotactic radiosurgery or fractionated radiotherapy depending on the situation.
Yes, the tumor itself or its treatment can affect surrounding normal pituitary tissue, leading to deficiency in one or more hormone systems that may require replacement therapy.
Yes, recurrence or regrowth can occur after surgery, medication discontinuation, or radiation, which is why long-term follow-up is standard.
Conclusion
Pituitary tumors are a genuinely diverse category whether a tumor is functioning or nonfunctioning, which specific hormone (if any) it produces, its size, and its relationship to the optic chiasm together determine what a specific diagnosis means and which combination of medication, surgery, radiation, and hormone replacement is appropriate. Most pituitary tumors are not cancer, but they are not automatically harmless either, and getting an accurate diagnosis including the hormonal workup that a tumor’s appearance on imaging alone cannot provide — is the most useful first step before deciding on a treatment path, in India or anywhere else.
This article is for general medical education and does not replace individualized advice from a qualified endocrinologist, neurosurgeon, or neuro-ophthalmologist. It is not a diagnosis, treatment recommendation, or guarantee of any outcome.
Popular Posts From Last Week
- August 26, 2026
- shifamhealth
If you or someone you love has just been told the diagnosis is adenoid cystic carcinoma, one of…
- August 27, 2026
- shifamhealth
Basal cell carcinoma (BCC) is the most common type of skin cancer, developing from basal cells in the…
- August 25, 2026
- shifamhealth
Angiosarcoma is one of the rarer cancers a person can be diagnosed with rare enough that many general…
- August 31, 2026
- shifamhealth
Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer. That description matters, it’s genuinely important not…
- August 30, 2026
- shifamhealth
Medically reviewed content · Published 2026 · Last reviewed August 2026 A neuroendocrine tumor (NET) is a growth…
- August 29, 2026
- shifamhealth
Medically reviewed content · Published 2026 · Last reviewed August 2026 Non-Hodgkin lymphoma (NHL) is a broad group…
- August 28, 2026
- shifamhealth
Medically reviewed content · Published 2026 · Last reviewed August 2026 Non-small cell lung cancer (NSCLC) is a…
- September 1, 2026
- shifamhealth
Medically reviewed content · Published 2026 · Last reviewed August 2026 A pituitary tumor is an abnormal growth…


